MX2016017312A - A pharmaceutical composition of solifenacin in a tablet by direct compression of oral administration, for the treatment of allopathy related to the malfunction of the bladder. - Google Patents

A pharmaceutical composition of solifenacin in a tablet by direct compression of oral administration, for the treatment of allopathy related to the malfunction of the bladder.

Info

Publication number
MX2016017312A
MX2016017312A MX2016017312A MX2016017312A MX2016017312A MX 2016017312 A MX2016017312 A MX 2016017312A MX 2016017312 A MX2016017312 A MX 2016017312A MX 2016017312 A MX2016017312 A MX 2016017312A MX 2016017312 A MX2016017312 A MX 2016017312A
Authority
MX
Mexico
Prior art keywords
allopathy
solifenacin
bladder
malfunction
tablet
Prior art date
Application number
MX2016017312A
Other languages
Spanish (es)
Inventor
Daniel Walls Flores Oliver
Rodríguez Hernández Ramón
Pedro Santos Maribel
Original Assignee
Laboratorios Liomont S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C V filed Critical Laboratorios Liomont S A De C V
Priority to MX2016017312A priority Critical patent/MX2016017312A/en
Publication of MX2016017312A publication Critical patent/MX2016017312A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the preparation of a tablet by direct compression or similar salts equivalent to solifenacin for the treatment of allopathy of the malfunction of the bladder.
MX2016017312A 2016-12-20 2016-12-20 A pharmaceutical composition of solifenacin in a tablet by direct compression of oral administration, for the treatment of allopathy related to the malfunction of the bladder. MX2016017312A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2016017312A MX2016017312A (en) 2016-12-20 2016-12-20 A pharmaceutical composition of solifenacin in a tablet by direct compression of oral administration, for the treatment of allopathy related to the malfunction of the bladder.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016017312A MX2016017312A (en) 2016-12-20 2016-12-20 A pharmaceutical composition of solifenacin in a tablet by direct compression of oral administration, for the treatment of allopathy related to the malfunction of the bladder.

Publications (1)

Publication Number Publication Date
MX2016017312A true MX2016017312A (en) 2018-06-19

Family

ID=63361763

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016017312A MX2016017312A (en) 2016-12-20 2016-12-20 A pharmaceutical composition of solifenacin in a tablet by direct compression of oral administration, for the treatment of allopathy related to the malfunction of the bladder.

Country Status (1)

Country Link
MX (1) MX2016017312A (en)

Similar Documents

Publication Publication Date Title
MX2015017201A (en) Pyrazolopyridine derivatives for use in the treatment of bladder cancer.
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
JP2016515522A5 (en)
CY1122469T1 (en) SUBLINGUAL PHARMACEUTICAL FORM OF RILOUZOLE
MX2015015518A (en) Methods and compositions for the treatment of cancer.
BR112017028140A2 (en) pharmaceutical formulations
EA201791110A1 (en) SUBLINGUAL INTRODUCTION OF RHYNESOL
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
EA032927B1 (en) Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
MX2021008432A (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2017009292A (en) (r)-2-methyl-piperazine derivatives as cxcr3 receptor modulators.
MX2020007268A (en) Dosing regimen of siponimod.
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.
CY1119522T1 (en) (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
MX2017014776A (en) Pharmaceutical combination of everolimus with dactolisib.
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
WO2016020408A3 (en) Compounds for preventing ototoxicity
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
MX2016017312A (en) A pharmaceutical composition of solifenacin in a tablet by direct compression of oral administration, for the treatment of allopathy related to the malfunction of the bladder.
TH167850B (en) (R) - Perlindole And its pharmacologically acceptable salt for use in medicinal drugs.
MD4458B1 (en) Use of Polybiolin drug in patients with liver cirrhosis